6505-01-126-1927 ( LIBRAX , LIBRAX CAPSULES , NDC52152-0018-02 , NDC00591-4007-01 , NDC00187-4100-10 , NDC00677-1247-01 , NDC00904-2503-60 , NDC00140-0007-49 , NDC00603-2714-21 )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-126-1927 | 6505 | 011261927 | CHLORDIAZEPOXIDE HYDROCHLORIDE A | 2667 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| CQLS | CAPSULE CONTENT FORM | ANY ACCEPTABLE |
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 5.000 MILLIGRAMS CHLORDIAZEPOXIDE HYDROCHLORIDE ACTIVE INGREDIENT AND 2.500 MILLIGRAMS CLIDINIUM BROMIDE ACTIVE INGREDIENT |
| PKTY | UNIT PACKAGE TYPE | PACKAGE |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 10 |
| CQCT | PRIMARY CONTAINER TYPE | STRIP |
| SUPP | SUPPLEMENTARY FEATURES | MEDSEP ITEM FOR DOD,HOFFMANN-LA ROCHE INC |
| CYLZ | CAPSULE PRIMARY CONTAINER CONTENT QUANTITY | 10.000 |
| AKJC | CAPSULE TYPE | ANY ACCEPTABLE |
| CSGS | ADMINISTRATION | ORAL |
| CXCY | PART NAME ASSIGNED BY CONTROLLING AGENCY | LIBRAX CAPSULES 10 STRIPS OF 10 CAPSULES |
| CBBL | FEATURES PROVIDED | INDIVIDUALLY SEALED |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| LIBRAX | 04493 | A | 1 | 5 | 4 | KX | |
| LIBRAX CAPSULES | 04493 | A | 1 | 5 | 4 | KX | |
| NDC52152-0018-02 | 2X896 | A | 2 | 5 | 4 | ZZ | |
| NDC00591-4007-01 | 62051 | A | 2 | 5 | 4 | ZZ | |
| NDC00187-4100-10 | 3AWU3 | A | 2 | 5 | 4 | ZZ | |
| NDC00677-1247-01 | 59225 | A | 2 | 5 | 4 | ZZ | |
| NDC00904-2503-60 | 0SYT3 | A | 2 | 5 | 4 | ZZ | |
| NDC00140-0007-49 | 04493 | A | 2 | 3 | 6 | 54 | |
| NDC00603-2714-21 | 0ET99 | A | 2 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| LIBRAX | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
| LIBRAX CAPSULES | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
| NDC52152-0018-02 | 2X896 | AMIDE PHARMACEUTICAL INC | F | A |
| NDC00591-4007-01 | 62051 | DANBURY PHARMACAL INC | A | A |
| NDC00187-4100-10 | 3AWU3 | VALEANT PHARMACEUTICALS | A | A |
| NDC00677-1247-01 | 59225 | BAXTER HEALTHCARE CORP | A | A |
| NDC00904-2503-60 | 0SYT3 | MAJOR PHARMACEUTICALS INC | F | A |
| NDC00140-0007-49 | 04493 | HOFFMANN-LA ROCHE INC. | F | A |
| NDC00603-2714-21 | 0ET99 | GENERICS BIDCO I LLC | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 02/06/1 | P | 3004909135 | 2667 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| DN | 9B----- | N | K | U/I CONTAINS 10 EA | |
| DS | I | K | U/I CONTAINS 10 EA | ||
| DF | ------- | F | K | U/I CONTAINS 10 EA | |
| DA | C2201X- | A | K | U/I CONTAINS 10 EA | |
| DN | 9B----- | N | R | REFER TO NON-STD NON-DMSB REV |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | P | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| DN | SMS | L | 1 | PG | Q | U | 9B----- | N | |
| DA | SMS | L | 1 | PG | Q | U | C2201X- | A | |
| DF | SMS | L | 1 | PG | Q | U | ------- | F | |
| DS | SMS | L | 1 | PG | Q | U | D |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|---|---|---|---|
| C | 2 | 2 | 01 | X |
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 058770 | Z | 33400 | W | 532 | Z | 9 | A | M | Z | DRUGS/MEDICINES/VITAMINS NOI |